COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,287 Articles (22,759 medRxiv, 8,528 bioRxiv)

Most recent first Previous |  Page 1755: Articles 17541-17550  | Next

Neutralizing IFNL3 Autoantibodies in Severe COVID-19 Identified Using Molecular Indexing of Proteins by Self-Assembly
Credle, J. J., Gunn, J., Sangkhapreecha, P., Monaco, D. R., Zheng, X. A., Tsai, H.-J., Wilbon, A., Morgenlander, W. R., Dong, Y., Jayaraman, S., Tosi, L., Parekkadan, B., Baer, A. N., Roederer, M., Bloch, E. M., Tobian, A. A. R., Zyskind, I., Silverberg, J. I., Rosenberg, A. Z., Cox, A. L., Lloyd, T., Mammen, A. L., Larman, H. B.
10.1101/2021.03.02.432977 — Posted: 2021-03-03
Blockade of SARS-CoV-2 infection in-vitro by highly potent PI3K-α/mTOR/BRD4 inhibitor
Acharya, A., Pandey, K., Thurman, M., Challagundla, K. B., Vann, K. R., Kutateladze, T. G., Morales, G. A., Durden, D. L., Byrareddy, S. N.
10.1101/2021.03.02.433604 — Posted: 2021-03-03
A pharmacophore model for SARS-CoV-2 3CLpro small molecule inhibitors and in vitro experimental validation of computationally screened inhibitors
Glaab, E., Manoharan, G. B., Abankwa, D.
10.1101/2021.03.02.433618 — Posted: 2021-03-03
Impact of COVID-19 pandemic on Black, Asian and Minority Ethnic (BAME) communities: a qualitative study on the perspectives of BAME community leaders
Mahmood, F., Acharya, D., Kumar, K., Paudyal, V.
10.1101/2021.03.03.21252286 — Posted: 2021-03-03
Modeling University Reopening in Low Risk Countries During COVID-19
Xi, J. Y., Chan, W. K.
10.1101/2021.03.02.21250607 — Posted: 2021-03-03
A novel, multiplexed RT-qPCR assay to distinguish lineage B.1.1.7 from the remaining SARS-CoV-2 lineages
Kovacova, V., Borsova, K., Paul, E. D., Radvanszka, M., Hajdu, R., Cabanova, V., Slavikova, M., Lickova, M., Lukacikova, L., Belak, A., Roussier, L., Kosticova, M., Liskova, A., Madarova, L., Stefkovicova, M., Reizigova, L., Novakova, E., Sabaka, P., Koscalova, A., Brejova, B., Vinar, T., Nosek, J., Cekan, P., Klempa, B.
10.1101/2021.02.09.21251168 — Posted: 2021-03-03
Recent Gains in Life Expectancy Reversed by the COVID-19 Pandemic
Aburto, J. M., Scholey, J., Zhang, L., Kashnitsky, I., Rahal, C., Missov, T., Mills, M. C., Dowd, J. B., Kashyap, R.
10.1101/2021.03.02.21252772 — Posted: 2021-03-03 Discussion: Onsite
Estimation of secondary household attack rates for emergent SARS-CoV-2 variants detected by genomic surveillance at a community-based testing site in San Francisco
Peng, J., Mann, S. A., Mitchell, A. M., Liu, J., Laurie, M. T., Sunshine, S., Pilarowski, G., Ayscue, P., Kistler, A., Vanaerschot, M., Li, L. M., McGeever, A., Chow, E. D., IDseq Team, , Marquez, C., Nakamura, R., Rubio, L., Chamie, G., Jones, D., Jacobo, J., Rojas, S., Tulier-Laiwa, V., Black, D., Martinez, J., Naso, J., Schwab, J., Petersen, M., Havlir, D., DeRisi, J. L.
10.1101/2021.03.01.21252705 — Posted: 2021-03-03
Atorvastatin effectively inhibits late replicative cycle steps of SARS-CoV-2 in vitro
Zapata-Cardona, M. I., Florez-Alvarez, L., Zapata-Builes, W., Guerra-Sandoval, A., Guerra-Almonacid, C., Hincapie-Garcia, J., Rugeles, M. T., Hernandez, J. C.
10.1101/2021.03.01.433498 — Posted: 2021-03-03
An overview of the National COVID-19 Chest Imaging Database: data quality and cohort analysis
Cushnan, D., Bennett, O., Berka, R., Bertolli, O., Chopra, A., Dorgham, S., Favaro, A., Ganepola, T., Halling-Brown, M., Imreh, G., Jacob, J., Jefferson, E., Lemarchand, F., Schofield, D., Wyatt, J. C., NCCID Collaborative
10.1101/2021.03.02.21252444 — Posted: 2021-03-03

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).